Ipilimumab With or Without Vaccine Therapy in Treating Patients With Previously Treated Stage IV Melanoma

NCT00357461 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Melanoma (Skin)

Interventions

BIOLOGICAL: gp100:209-217(210M) peptide vaccine
BIOLOGICAL: gp100:280-288(288V) peptide vaccine
BIOLOGICAL: incomplete Freund's adjuvant
BIOLOGICAL: ipilimumab

Sponsor

Bristol-Myers Squibb

Collaborators

[object Object]